Browse Arkansas Code titles and sections
12-64-847. Use or possession of a controlled substance.
Arkansas Code — all titles (historical 2020) · legal_authorities
12-64-847. Use or possession of a controlled substance.
(a) As used in this section, “controlled substance” means:
(1) Amphetamine;
(2) Cocaine;
(3) Heroin;
(4) Lysergic acid diethylamide;
(5) Marijuana;
(6) Methamphetamine;
(7) Opium;
(8) Phencyclidine;
(9) Barbituric acid, including phenobarbital and secobarbital; or
(10) Any substance that is included in Schedules I-VI established by the Controlled Substances Act of 1970, 21 U.S.C. § 812, or the Uniform Controlled Substances Act, § 5-64-101 et seq.
(b) A person subject to this code who wrongfully uses, is under the influence of, or possesses a controlled substance shall be punished as a court-martial may direct.
(c) A person subject to this code who wrongfully possesses the metabolites of a controlled substance in his or her blood or urine shall be punished as a court-martial may direct.
Source: Arkansas Code — historical release 78 (November 6, 2020) · 12-64-847
Stored review status: Historical 2020-11-06 source release; later amendments not reconciled; machine-extracted, not independently legally reviewed; source heading status: text_in_historical_source. A text match is a research starting point; applicability is not established.
Issuing source page ↗
Authority boundary: historical statutory source snapshot not current law.
Open the recorded source website ↗
Record provenance
Stable record: arkansas_code:legal_authorities:12-64-847
Source file: gov.ar.code.title.12.odt
Pages: Not recorded – Not recorded
Passage SHA-256: 975537011d919988307d94b4abb7417509a6f60da8288ad110b974ded5726f2a
Source location: content.xml paragraph 19726
Stored source content
12-64-847. Use or possession of a controlled substance.
(a) As used in this section, “controlled substance” means:
(1) Amphetamine;
(2) Cocaine;
(3) Heroin;
(4) Lysergic acid diethylamide;
(5) Marijuana;
(6) Methamphetamine;
(7) Opium;
(8) Phencyclidine;
(9) Barbituric acid, including phenobarbital and secobarbital; or
(10) Any substance that is included in Schedules I-VI established by the Controlled Substances Act of 1970, 21 U.S.C. § 812, or the Uniform Controlled Substances Act, § 5-64-101 et seq.
(b) A person subject to this code who wrongfully uses, is under the influence of, or possesses a controlled substance shall be punished as a court-martial may direct.
(c) A person subject to this code who wrongfully possesses the metabolites of a controlled substance in his or her blood or urine shall be punished as a court-martial may direct.
Cross-references
Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.
Federal law — U.S. Code and appendices · legal_authorities
**(a) Establishment** There are established five schedules of controlled substances, to be known as schedules I, II, III, IV, and V. Such schedules shall initially consist of the substances listed in this section. The schedules established by this section shall be updated and republished on a semiannual basis during the two-year period beginning one year after October 27, 1970, and shall be updated and republished on an annual basis thereafter.11 See Amendment of Schedules of Controlled Substances note below.
**(b) Placement on schedules; findings required** Except where control is required by United States obligations under an international treaty, convention, or protocol, in effect on October 27, 1970, and except in the case of an immediate precursor, a drug or other substance may not be placed in any schedule unless the findings required for such schedule are made with respect to such drug or other substance. The findings required for each of the schedules are as follows:
(1) **Schedule I.—**
(A) The drug or other substance has a high potential for abuse.
(B) The drug or other substance has no currently accepted medical use in treatment in the United States.
(C) There is a lack of accepted safety for use of the drug or other substance under medical supervision.
(2) **Schedule II.—**
(A) The drug or other substance has a high potential for abuse.
(B) The drug or other substance has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions.
(C) Abuse of the drug or other substances may lead to severe psychological or physical dependence.
(3) **Schedule III.—**
(A) The drug or other substance has a potential for abuse less than the drugs or other substances in schedules I and
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 812
Stored review status: release_metadata_unconfirmed. The source passage cites 21 U.S.C. § 812. This identifies an authority to review, not proof of applicability.
Federal law — U.S. Code and appendices · legal_authorities
Page 799
TITLE 21—FOOD AND DRUGS
§ 812
1 See Amendment of Schedules of Controlled Substances note
below.
3768, which enacted sections 801a, 830, and 852 of this
title, amended sections 352, 802, 811, 812, 823, 827, 841 to
843, 872, 881, 952, 953, and 965 of this title and section
242a of Title 42, The Public Health and Welfare, re-
pealed section 830 of this title effective Jan. 1, 1981, and
enacted provisions set out as notes under sections 801,
801a, 812, and 830 of this title. For complete classifica-
tion of this Act to the Code, see Short Title of 1978
Amendment note set out under section 801 of this title
and Tables.
This subchapter and subchapter II of this chapter, re-
ferred to in subsec. (g)(1), was in the original ‘‘titles II
and III of the Comprehensive Drug Abuse Prevention
and Control Act’’, which was translated as meaning ti-
tles II and III of the Comprehensive Drug Abuse Pre-
vention and Control Act of 1970, Pub. L. 91–513, Oct. 27,
1970, 84 Stat. 1242, 1285, to reflect the probable intent of
Congress. Title II is classified principally to this sub-
chapter and part A of title III comprises subchapter II
of this chapter. For complete classification of this Act
to the Code, see Short Title notes set out under section
801 of this title and Tables.
AMENDMENTS
2015—Subsec. (j). Pub. L. 114–89 added subsec. (j).
2014—Subsec. (i). Pub. L. 113–260 added subsec. (i).
2012—Subsec. (h)(2). Pub. L. 112–144 substituted ‘‘2
years’’ for ‘‘one year’’ and ‘‘1 year’’ for ‘‘six months’’.
2004—Subsec. (g)(1). Pub. L. 108–358, § 2(b)(1), sub-
stituted ‘‘drug which contains a controlled substance
from the application of this subchapter and subchapter
II of this chapter if such drug’’ for ‘‘substance from a
schedule if such substance’’.
Subsec. (g)
Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 812
Stored review status: historical_2024_not_currentness_verified. The source passage cites 21 U.S.C. § 812. This identifies an authority to review, not proof of applicability.
Arkansas Code — all titles (historical 2020) · legal_authorities
5-64-101. Definitions.
As used in this chapter:
(1) “Administer” means the direct application of a controlled substance, whether by injection, inhalation, ingestion, or any other means to the body of a patient or research subject by:
(A) A practitioner; or
(B) The patient or research subject at the direction and in the presence of the practitioner;
(2)(A) “Agent” means an authorized person who acts on behalf of or at the direction of a manufacturer, distributor, or dispenser.
(B) “Agent” does not include a common or contract carrier, public warehouseman, or employee of the common or contract carrier or warehouseman;
(3)(A) “Anabolic steroid” means any drug or hormonal substance, chemically and pharmacologically related to testosterone, other than estrogens, progestin, and corticosteroid that promotes muscle growth.
(B)(i) “Anabolic steroid” does not include an anabolic steroid that is expressly intended for administration through an implant to cattle or another nonhuman species and that has been approved by the Secretary of the Department of Health for such administration.
(ii) If any person prescribes, dispenses, or distributes a steroid described in subdivision (3)(B)(i) of this section for human use, the person is considered to have prescribed, dispensed, or distributed an anabolic steroid within the meaning of this subdivision (3);
(4) “Controlled substance” means a drug, substance, or immediate precursor in Schedules I through VI;
(5)(A) “Counterfeit substance” means a noncontrolled substance, that by overall dosage unit appearance including color, shape, size, markings, packaging, labeling, and overall appearance or upon the basis of representations made to the recipient, purports to be a controlled substance or to have the physical or psychol
Source: Arkansas Code — historical release 78 (November 6, 2020) · 5-64-101
Stored review status: Historical 2020-11-06 source release; later amendments not reconciled; machine-extracted, not independently legally reviewed; source heading status: text_in_historical_source. The source passage cites 5-64-101. This identifies an authority to review, not proof of applicability.